Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free CBLL Stock Alerts

CeriBell (CBLL) Financials

CeriBell logo
$20.06 -0.14 (-0.69%)
Closing price 04:00 PM Eastern
Extended Trading
$20.04 -0.02 (-0.10%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for CeriBell

Annual Income Statements for CeriBell

This table shows CeriBell's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -29 -40 -53
Consolidated Net Income / (Loss)		 -29 -40 -53
Net Income / (Loss) Continuing Operations		 -29 -40 -53
Total Pre-Tax Income 		-29 -40 -53
Total Operating Income		 -30 -40 -58
Total Gross Profit		 38 57 78
Total Revenue		 45 65 89
Operating Revenue		 45 65 89
Total Cost of Revenue		 7.06 8.69 11
Operating Cost of Revenue		 7.06 8.69 11
Total Operating Expenses		 68 96 137
Selling, General & Admin Expense		 20 34 44
Marketing Expense		 39 49 73
Research & Development Expense		 9.00 14 19
Total Other Income / (Expense), net		 0.59 -0.75 4.99
Interest Expense		 2.10 1.99 1.89
Other Income / (Expense), net		 2.69 1.25 6.88
Income Tax Expense		 0.01 0.00 0.00
Basic Earnings per Share		 ($5.56) ($3.39) ($1.46)
Weighted Average Basic Shares Outstanding		 5.30M 11.95M 36.54M
Diluted Earnings per Share		 ($5.56) ($3.39) ($1.46)
Weighted Average Diluted Shares Outstanding		 5.30M 11.95M 36.54M
Weighted Average Basic & Diluted Shares Outstanding		 - 35.87M 37.64M

Quarterly Income Statements for CeriBell

This table shows CeriBell's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14
Consolidated Net Income / (Loss)		 -7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14
Net Income / (Loss) Continuing Operations		 -7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14
Total Pre-Tax Income 		-7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14
Total Operating Income		 -7.16 -8.45 -8.44 -9.94 -13 -14 -15 -15 -15
Total Gross Profit		 9.73 12 13 15 16 18 19 20 22
Total Revenue		 12 14 15 17 19 20 21 23 25
Operating Revenue		 12 14 15 17 19 20 21 23 25
Total Cost of Revenue		 1.89 2.06 2.16 2.18 2.30 2.48 2.52 2.65 3.14
Operating Cost of Revenue		 1.89 2.06 2.16 2.18 2.30 2.48 2.52 2.65 3.14
Total Operating Expenses		 17 21 22 25 29 32 34 35 36
Selling, General & Admin Expense		 4.99 7.24 7.61 9.03 9.97 9.94 11 11 12
Marketing Expense		 9.59 11 11 13 15 18 17 19 19
Research & Development Expense		 2.31 2.98 3.27 3.40 3.91 4.25 4.85 4.98 5.06
Total Other Income / (Expense), net		 0.11 -0.07 -0.51 -0.48 0.31 1.43 1.31 1.18 1.07
Interest Expense		 0.53 0.44 0.53 0.53 0.50 0.47 0.48 0.48 0.46
Other Income / (Expense), net		 0.64 0.37 0.02 0.05 0.81 1.90 1.79 1.66 1.53
Basic Earnings per Share		 ($1.32) ($1.56) ($1.61) ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35)
Weighted Average Basic Shares Outstanding		 5.34M 5.46M 5.56M 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M
Diluted Earnings per Share		 ($1.32) ($1.56) ($1.61) ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35)
Weighted Average Diluted Shares Outstanding		 5.34M 5.46M 5.56M 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 35.82M 35.87M 36.14M 36.66M 37.10M 37.64M

Annual Cash Flow Statements for CeriBell

This table details how cash moves in and out of CeriBell's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -34 160 -154
Net Cash From Operating Activities		 -29 -35 -41
Net Cash From Continuing Operating Activities		 -29 -35 -41
Net Income / (Loss) Continuing Operations		 -29 -40 -53
Consolidated Net Income / (Loss)		 -29 -40 -53
Depreciation Expense		 0.85 1.14 1.34
Amortization Expense		 0.36 0.38 -1.60
Non-Cash Adjustments To Reconcile Net Income		 2.02 6.47 12
Changes in Operating Assets and Liabilities, net		 -2.92 -2.58 1.35
Net Cash From Investing Activities		 -1.76 -1.60 -118
Net Cash From Continuing Investing Activities		 -1.76 -1.60 -118
Purchase of Property, Plant & Equipment		 -0.98 -1.34 -0.77
Purchase of Investments		 - 0.00 -211
Sale and/or Maturity of Investments		 - 0.00 94
Other Investing Activities, net		 -0.78 -0.26 -0.76
Net Cash From Financing Activities		 -2.82 197 5.05
Net Cash From Continuing Financing Activities		 -2.82 197 5.05
Repayment of Debt		 -3.75 -0.30 -0.15
Repurchase of Preferred Equity		 0.00 -5.05 0.00
Issuance of Debt		 0.00 7.91 0.00
Issuance of Common Equity		 - 1.13 5.44
Other Financing Activities, net		 0.93 193 -0.24
Cash Interest Paid		 1.73 1.95 1.89

Quarterly Cash Flow Statements for CeriBell

This table details how cash moves in and out of CeriBell's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents		 -11 -2.00 -8.13 -10 180 -41 -113 -16 17
Net Cash From Operating Activities		 -6.68 -9.55 -6.98 -8.54 -9.98 -11 -7.53 -11 -11
Net Cash From Continuing Operating Activities		 -6.68 -9.55 -6.98 -8.54 -9.98 -11 -7.53 -11 -11
Net Income / (Loss) Continuing Operations		 -8.27 -8.52 -8.94 -10 -13 -13 -14 -13 -14
Consolidated Net Income / (Loss)		 -8.27 -8.52 -8.94 -10 -13 -13 -14 -13 -14
Depreciation Expense		 0.23 0.26 0.28 0.24 0.36 0.34 0.32 0.39 0.29
Amortization Expense		 0.09 0.09 0.11 0.09 0.09 0.08 -0.37 -0.80 -0.52
Non-Cash Adjustments To Reconcile Net Income		 0.67 0.79 1.23 1.45 2.89 1.92 3.24 3.08 3.27
Changes in Operating Assets and Liabilities, net		 0.61 -2.16 0.35 0.09 -0.74 -0.97 2.91 -0.30 -0.30
Net Cash From Investing Activities		 -0.68 -0.13 -1.16 0.18 -0.49 -30 -108 -6.94 26
Net Cash From Continuing Investing Activities		 -0.68 -0.13 -1.16 0.18 -0.49 -30 -108 -6.94 26
Purchase of Property, Plant & Equipment		 -0.48 -0.10 -0.32 -0.57 -0.36 -0.15 -0.07 -0.37 -0.18
Purchase of Investments		 - 0.00 - - - -29 -113 -46 -22
Sale and/or Maturity of Investments		 - - - - - - - 40 49
Other Investing Activities, net		 -0.21 -0.04 -0.84 0.75 -0.14 -0.13 -0.16 -0.09 -0.37
Net Cash From Financing Activities		 -3.46 7.68 -0.00 -1.89 191 0.00 2.01 1.64 1.40
Net Cash From Continuing Financing Activities		 -3.46 7.68 -0.00 -1.89 191 0.00 2.01 1.64 1.40
Issuance of Common Equity		 - 0.12 0.49 0.33 0.19 0.15 2.01 1.64 1.64
Other Financing Activities, net		 0.93 - - -2.22 191 - - - -0.24
Cash Interest Paid		 0.42 0.39 0.53 0.27 0.76 0.47 0.48 0.48 0.46

Annual Balance Sheets for CeriBell

This table presents CeriBell's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 59 225 196
Total Current Assets		 52 217 187
Cash & Equivalents		 34 194 40
Short-Term Investments		 - 0.00 119
Accounts Receivable		 7.96 11 15
Inventories, net		 5.87 6.94 7.29
Prepaid Expenses		 2.13 3.25 2.91
Other Current Assets		 1.52 1.84 2.21
Plant, Property, & Equipment, net		 1.58 2.31 2.03
Total Noncurrent Assets		 5.38 5.83 7.06
Other Noncurrent Operating Assets		 5.38 5.83 7.06
Total Liabilities & Shareholders' Equity		 59 225 196
Total Liabilities		 24 34 40
Total Current Liabilities		 22 13 19
Accounts Payable		 0.73 1.14 2.84
Accrued Expenses		 7.54 10 14
Current Deferred Revenue		 - 0.10 0.10
Other Current Liabilities		 1.50 1.70 1.92
Total Noncurrent Liabilities		 2.16 21 21
Long-Term Debt		 0.00 20 20
Noncurrent Deferred Revenue		 - 0.03 0.00
Other Noncurrent Operating Liabilities		 2.16 1.67 1.47
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -112 191 155
Total Preferred & Common Equity		 -112 191 155
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 -112 191 155
Common Stock		 14 358 376
Retained Earnings		 -126 -167 -220
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 0.16

Quarterly Balance Sheets for CeriBell

This table presents CeriBell's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets		 47 213 208 200
Total Current Assets		 35 205 200 192
Cash & Equivalents		 14 153 40 24
Short-Term Investments		 - 29 137 145
Accounts Receivable		 9.97 11 12 12
Inventories, net		 6.91 6.55 6.00 6.02
Prepaid Expenses		 2.27 2.85 2.02 2.86
Other Current Assets		 1.70 2.02 2.02 2.15
Plant, Property, & Equipment, net		 2.27 2.13 2.11 2.06
Total Noncurrent Assets		 9.83 5.93 5.80 5.66
Other Noncurrent Operating Assets		 9.83 5.93 5.80 5.66
Total Liabilities & Shareholders' Equity		 47 213 208 200
Total Liabilities		 36 33 36 35
Total Current Liabilities		 13 12 15 15
Accounts Payable		 2.78 1.37 2.44 2.18
Accrued Expenses		 8.57 8.30 10 11
Current Deferred Revenue		 - 0.20 0.22 0.14
Other Current Liabilities		 1.74 1.96 1.93 1.94
Total Noncurrent Liabilities		 23 21 21 20
Long-Term Debt		 19 20 20 20
Noncurrent Deferred Revenue		 - 0.01 0.01 0.00
Other Noncurrent Operating Liabilities		 3.04 1.13 0.83 0.53
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -136 181 172 164
Total Preferred & Common Equity		 -136 181 172 164
Preferred Stock		 - 0.00 0.00 0.00
Total Common Equity		 -136 181 172 164
Common Stock		 18 361 366 371
Retained Earnings		 -154 -180 -193 -207
Accumulated Other Comprehensive Income / (Loss)		 - -0.01 0.01 0.14

Annual Metrics And Ratios for CeriBell

This table displays calculated financial ratios and metrics derived from CeriBell's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - -
Revenue Growth		 0.00% 44.71% 36.09%
EBITDA Growth		 0.00% -41.29% -40.17%
EBIT Growth		 0.00% -40.61% -33.95%
NOPAT Growth		 0.00% -32.18% -47.08%
Net Income Growth		 0.00% -37.30% -32.03%
EPS Growth		 0.00% 39.03% 56.93%
Operating Cash Flow Growth		 0.00% -20.18% -16.45%
Free Cash Flow Firm Growth		 0.00% 0.00% -27.69%
Invested Capital Growth		 0.00% 30.84% -2.86%
Revenue Q/Q Growth		 0.00% 0.00% 7.55%
EBITDA Q/Q Growth		 0.00% 0.00% -3.33%
EBIT Q/Q Growth		 0.00% 0.00% -1.96%
NOPAT Q/Q Growth		 0.00% 0.00% -3.02%
Net Income Q/Q Growth		 0.00% 0.00% -1.81%
EPS Q/Q Growth		 0.00% 0.00% -380.77%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -2.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 3.94%
Profitability Metrics		 - - -
Gross Margin		 84.38% 86.72% 87.89%
EBITDA Margin		 -57.81% -56.45% -58.14%
Operating Margin		 -66.43% -60.68% -65.57%
EBIT Margin		 -60.49% -58.77% -57.85%
Profit (Net Income) Margin		 -65.15% -61.82% -59.97%
Tax Burden Percent		 100.04% 100.00% 100.00%
Interest Burden Percent		 107.67% 105.18% 103.67%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -168.26% -192.69% -253.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 -131.03% -179.87% -245.64%
Return on Net Nonoperating Assets (RNNOA)		 84.46% 156.94% 222.79%
Return on Equity (ROE)		 -83.80% -35.75% -30.83%
Cash Return on Invested Capital (CROIC)		 0.00% -219.41% -250.72%
Operating Return on Assets (OROA)		 -46.43% -27.05% -24.46%
Return on Assets (ROA)		 -50.01% -28.46% -25.36%
Return on Common Equity (ROCE)		 267.54% -12.46% -30.83%
Return on Equity Simple (ROE_SIMPLE)		 26.25% -21.16% 0.00%
Net Operating Profit after Tax (NOPAT)		 -21 -28 -41
NOPAT Margin		 -46.50% -42.47% -45.90%
Net Nonoperating Expense Percent (NNEP)		 -37.22% -12.82% -7.97%
Return On Investment Capital (ROIC_SIMPLE)		 20.94% -13.19% -23.34%
Cost of Revenue to Revenue		 15.62% 13.28% 12.11%
SG&A Expenses to Revenue		 44.86% 51.71% 49.91%
R&D to Revenue		 19.89% 20.72% 21.49%
Operating Expenses to Revenue		 150.81% 147.39% 153.46%
Earnings before Interest and Taxes (EBIT)		 -27 -38 -52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -26 -37 -52
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 1.62 5.16
Price to Tangible Book Value (P/TBV)		 0.00 1.62 5.16
Price to Revenue (P/Rev)		 3.99 4.73 9.00
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 24.41 8.22 41.67
Enterprise Value to Revenue (EV/Rev)		 6.75 2.05 7.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.34 0.10 0.13
Long-Term Debt to Equity		 0.00 0.10 0.13
Financial Leverage		 -0.64 -0.87 -0.91
Leverage Ratio		 1.68 1.26 1.22
Compound Leverage Factor		 1.80 1.32 1.26
Debt to Total Capital		 25.18% 9.28% 11.31%
Short-Term Debt to Total Capital		 25.18% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 9.28% 11.31%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 313.69% 0.00% 0.00%
Common Equity to Total Capital		 -238.87% 90.72% 88.69%
Debt to EBITDA		 -0.45 -0.53 -0.38
Net Debt to EBITDA		 0.87 4.73 2.69
Long-Term Debt to EBITDA		 0.00 -0.53 -0.38
Debt to NOPAT		 -0.56 -0.70 -0.48
Net Debt to NOPAT		 1.08 6.29 3.41
Long-Term Debt to NOPAT		 0.00 -0.70 -0.48
Altman Z-Score		 1.40 5.20 10.92
Noncontrolling Interest Sharing Ratio		 419.26% 65.13% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 2.41 16.73 9.73
Quick Ratio		 1.97 15.80 9.08
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -32 -40
Operating Cash Flow to CapEx		 -2,966.33% -2,615.15% -5,320.47%
Free Cash Flow to Firm to Interest Expense		 0.00 -15.89 -21.38
Operating Cash Flow to Interest Expense		 -13.90 -17.59 -21.59
Operating Cash Flow Less CapEx to Interest Expense		 -14.37 -18.26 -22.00
Efficiency Ratios		 - - -
Asset Turnover		 0.77 0.46 0.42
Accounts Receivable Turnover		 5.69 6.95 6.87
Inventory Turnover		 1.20 1.36 1.52
Fixed Asset Turnover		 28.68 33.65 41.01
Accounts Payable Turnover		 9.65 9.27 5.42
Days Sales Outstanding (DSO)		 64.20 52.52 53.14
Days Inventory Outstanding (DIO)		 303.29 268.80 240.62
Days Payable Outstanding (DPO)		 37.83 39.36 67.34
Cash Conversion Cycle (CCC)		 329.66 281.96 226.42
Capital & Investment Metrics		 - - -
Invested Capital		 12 16 16
Invested Capital Turnover		 3.62 4.54 5.53
Increase / (Decrease) in Invested Capital		 0.00 3.86 -0.47
Enterprise Value (EV)		 305 134 662
Market Capitalization		 180 309 801
Book Value per Share		 ($21.16) $5.34 $4.19
Tangible Book Value per Share		 ($21.16) $5.34 $4.19
Total Capital		 47 211 175
Total Debt		 12 20 20
Total Long-Term Debt		 0.00 20 20
Net Debt		 -23 -175 -139
Capital Expenditures (CapEx)		 0.98 1.34 0.77
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 7.70 9.91 8.27
Debt-free Net Working Capital (DFNWC)		 42 204 168
Net Working Capital (NWC)		 30 204 168
Net Nonoperating Expense (NNE)		 8.44 13 13
Net Nonoperating Obligations (NNO)		 -23 -175 -139
Total Depreciation and Amortization (D&A)		 1.21 1.52 -0.26
Debt-free, Cash-free Net Working Capital to Revenue		 17.03% 15.15% 9.28%
Debt-free Net Working Capital to Revenue		 93.30% 312.15% 188.10%
Net Working Capital to Revenue		 67.14% 312.15% 188.10%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 ($3.39) ($1.46)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 11.95M 36.54M
Adjusted Diluted Earnings per Share		 $0.00 ($3.39) ($1.46)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 11.95M 36.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 35.87M 37.64M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -28 -41
Normalized NOPAT Margin		 -46.50% -42.47% -45.90%
Pre Tax Income Margin		 -65.13% -61.82% -59.97%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -13.04 -19.31 -27.26
NOPAT to Interest Expense		 -10.02 -13.95 -21.63
EBIT Less CapEx to Interest Expense		 -13.51 -19.98 -27.67
NOPAT Less CapEx to Interest Expense		 -10.49 -14.63 -22.04
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for CeriBell

This table displays calculated financial ratios and metrics derived from CeriBell's official financial filings.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 48.09% 0.00% 42.30% 38.42% 31.37% 33.72%
EBITDA Growth		 0.00% 0.00% 0.00% -51.59% 0.00% -53.60% -64.56% -40.17% -14.36%
EBIT Growth		 0.00% 0.00% 0.00% -51.59% 0.00% -52.19% -56.50% -31.33% -8.18%
NOPAT Growth		 0.00% 0.00% 0.00% -38.71% 0.00% -68.07% -77.26% -47.40% -13.29%
Net Income Growth		 0.00% 0.00% 0.00% -47.68% 0.00% -49.95% -52.59% -29.26% -7.56%
EPS Growth		 0.00% 0.00% 0.00% -40.15% 0.00% 76.92% 76.40% 80.00% -121.47%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% -49.44% -19.40% -7.98% -29.92% -8.01%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 63.32% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -9.12% -2.86%
Revenue Q/Q Growth		 0.00% 0.00% 6.35% 0.00% 7.79% 0.00% 3.46% 6.56% 9.72%
EBITDA Q/Q Growth		 0.00% 0.00% -3.71% 0.00% -21.64% 0.00% -11.10% -1.37% 0.75%
EBIT Q/Q Growth		 0.00% 0.00% -4.04% 0.00% -22.15% 0.00% -6.99% 1.37% -0.62%
NOPAT Q/Q Growth		 0.00% 0.00% 0.21% 0.00% -29.66% 0.00% -5.24% 2.04% 0.35%
Net Income Q/Q Growth		 0.00% 0.00% -4.93% 0.00% -20.73% 0.00% -6.78% 1.30% -0.46%
EPS Q/Q Growth		 0.00% 0.00% -3.21% 0.00% 188.11% 0.00% -5.56% 2.63% 5.41%
Operating Cash Flow Q/Q Growth		 0.00% -43.07% 26.95% 0.00% -16.78% -14.32% 33.94% -47.33% 2.92%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 100.00% 0.00% 10.34% 64.94% -11.82%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -2.76% 0.00% -19.05% 6.08% 3.94%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 83.77% 85.71% 85.92% 87.30% 87.61% 87.88% 88.13% 88.28% 87.33%
EBITDA Margin		 -56.17% -53.75% -52.41% -57.50% -62.70% -58.02% -62.31% -59.28% -53.62%
Operating Margin		 -61.70% -58.70% -55.08% -57.79% -69.52% -69.33% -70.53% -64.84% -58.89%
EBIT Margin		 -56.17% -56.15% -54.93% -57.50% -65.16% -60.06% -62.11% -57.48% -52.72%
Profit (Net Income) Margin		 -60.75% -59.17% -58.38% -60.58% -67.85% -62.35% -64.36% -59.61% -54.58%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 108.16% 105.38% 106.28% 105.36% 104.13% 103.83% 103.62% 103.70% 103.54%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% -194.74% -390.11% -530.59% -234.19% -227.78%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% -192.70% -386.64% -526.56% -229.71% -225.67%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 176.22% 348.59% 482.49% 187.69% 204.67%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% -18.52% -41.52% -48.10% -46.49% -23.10%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% -193.55% 0.00% 0.00% 0.00% -250.72%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% -30.00% -20.12% -23.15% -38.61% -22.29%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% -31.24% -20.90% -23.99% -40.04% -23.08%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% -6.46% -41.52% -48.10% -7.44% -23.10%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% -24.72% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -5.01 -5.92 -5.90 -6.96 -9.02 -9.94 -10 -10 -10
NOPAT Margin		 -43.19% -41.09% -38.55% -40.45% -48.66% -48.53% -49.37% -45.39% -41.23%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 128.50% -2.03% -3.47% -4.03% -4.48% -2.11%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - -4.28% -4.96% -5.46% -5.58% -5.83%
Cost of Revenue to Revenue		 16.23% 14.29% 14.08% 12.70% 12.39% 12.12% 11.87% 11.72% 12.67%
SG&A Expenses to Revenue		 42.98% 50.24% 49.70% 52.51% 53.77% 48.48% 53.59% 48.86% 48.90%
R&D to Revenue		 19.88% 20.72% 21.35% 19.74% 21.11% 20.72% 22.89% 22.06% 20.42%
Operating Expenses to Revenue		 145.47% 144.41% 141.00% 145.09% 157.13% 157.21% 158.66% 153.12% 146.22%
Earnings before Interest and Taxes (EBIT)		 -6.52 -8.09 -8.41 -9.89 -12 -12 -13 -13 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.52 -7.74 -8.03 -9.89 -12 -12 -13 -13 -13
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 1.62 3.81 3.95 2.58 5.16
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 1.62 3.81 3.95 2.58 5.16
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 4.73 9.64 8.78 5.11 9.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 19.81 8.22 29.56 36.23 17.93 41.67
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 2.05 7.36 6.74 3.31 7.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 1.71 0.10 0.11 0.11 0.12 0.13
Long-Term Debt to Equity		 0.00 0.00 0.00 1.71 0.10 0.11 0.11 0.12 0.13
Financial Leverage		 0.00 0.00 0.00 0.47 -0.91 -0.90 -0.92 -0.82 -0.91
Leverage Ratio		 0.00 0.00 0.00 4.12 1.26 1.18 1.21 1.40 1.22
Compound Leverage Factor		 0.00 0.00 0.00 4.34 1.31 1.23 1.25 1.46 1.26
Debt to Total Capital		 0.00% 0.00% 0.00% 63.04% 9.28% 9.78% 10.26% 10.74% 11.31%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 63.04% 9.28% 9.78% 10.26% 10.74% 11.31%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 476.65% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% -439.69% 90.72% 90.22% 89.74% 89.26% 88.69%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.53 -0.48 -0.43 -0.39 -0.38
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 4.73 3.97 3.41 2.97 2.69
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.53 -0.48 -0.43 -0.39 -0.38
Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.70 -0.62 -0.54 -0.50 -0.48
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 6.29 5.12 4.34 3.75 3.41
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.70 -0.62 -0.54 -0.50 -0.48
Altman Z-Score		 0.00 0.00 0.00 0.00 5.58 12.74 11.41 6.97 11.57
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 65.13% 0.00% 0.00% 83.99% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.00 0.00 0.00 2.67 16.73 17.36 13.31 12.65 9.73
Quick Ratio		 0.00 0.00 0.00 1.84 15.80 16.40 12.64 11.92 9.08
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 -24 0.00 -28 -25 -8.72 -9.75
Operating Cash Flow to CapEx		 0.00% -10,052.63% -2,173.21% 0.00% -2,794.12% -7,704.73% -10,609.86% -3,007.59% -6,018.99%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 -44.85 0.00 -58.90 -52.15 -18.17 -21.10
Operating Cash Flow to Interest Expense		 0.00 -21.95 -13.21 0.00 -19.99 -24.21 -15.79 -23.12 -23.32
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -22.17 -13.82 0.00 -20.71 -24.52 -15.94 -23.89 -23.71
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.46 0.34 0.37 0.67 0.42
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 6.95 6.33 6.29 7.46 6.87
Inventory Turnover		 0.00 0.00 0.00 0.00 1.36 1.39 1.58 1.54 1.52
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 33.65 33.66 36.78 38.31 41.01
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 9.27 6.66 3.88 4.01 5.42
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 52.52 57.65 58.05 48.94 53.14
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 268.80 262.26 230.99 237.37 240.62
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 39.36 54.83 93.97 90.99 67.34
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 281.96 265.09 195.06 195.32 226.42
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 0.00 0.00 17 16 18 14 15 16
Invested Capital Turnover		 0.00 0.00 0.00 0.00 4.00 8.04 10.75 5.16 5.53
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 17 0.00 18 14 -1.53 -0.47
Enterprise Value (EV)		 0.00 0.00 0.00 333 134 526 522 274 662
Market Capitalization		 180 180 180 180 309 689 680 423 801
Book Value per Share		 $0.00 $0.00 $0.00 ($24.13) $5.34 $5.04 $4.76 $4.48 $4.19
Tangible Book Value per Share		 $0.00 $0.00 $0.00 ($24.13) $5.34 $5.04 $4.76 $4.48 $4.19
Total Capital		 0.00 0.00 0.00 31 211 200 192 184 175
Total Debt		 0.00 0.00 0.00 19 20 20 20 20 20
Total Long-Term Debt		 0.00 0.00 0.00 19 20 20 20 20 20
Net Debt		 0.00 0.00 0.00 5.39 -175 -163 -158 -149 -139
Capital Expenditures (CapEx)		 0.00 0.10 0.32 0.00 0.36 0.15 0.07 0.37 0.18
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 7.76 9.91 11 7.34 8.10 8.27
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 22 204 194 185 177 168
Net Working Capital (NWC)		 0.00 0.00 0.00 22 204 194 185 177 168
Net Nonoperating Expense (NNE)		 2.04 2.60 3.04 3.46 3.56 2.83 3.18 3.21 3.31
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 5.39 -175 -163 -158 -149 -139
Total Depreciation and Amortization (D&A)		 0.00 0.35 0.39 0.00 0.46 0.42 -0.04 -0.41 -0.22
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 15.15% 15.22% 9.49% 9.78% 9.28%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 312.15% 270.62% 238.66% 213.30% 188.10%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 312.15% 270.62% 238.66% 213.30% 188.10%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 35.82M 35.87M 36.14M 36.66M 37.10M 37.64M
Normalized Net Operating Profit after Tax (NOPAT)		 -5.01 -5.92 -5.90 -6.96 -9.02 -9.94 -10 -10 -10
Normalized NOPAT Margin		 -43.19% -41.09% -38.55% -40.45% -48.66% -48.53% -49.37% -45.39% -41.23%
Pre Tax Income Margin		 -60.75% -59.17% -58.38% -60.58% -67.85% -62.35% -64.36% -59.61% -54.58%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 -12.26 -18.59 -15.93 -18.65 -24.20 -26.13 -27.60 -27.05 -28.28
NOPAT to Interest Expense		 -9.43 -13.60 -11.18 -13.12 -18.07 -21.11 -21.94 -21.36 -22.12
EBIT Less CapEx to Interest Expense		 0.00 -18.81 -16.54 0.00 -24.92 -26.44 -27.75 -27.82 -28.67
NOPAT Less CapEx to Interest Expense		 0.00 -13.82 -11.79 0.00 -18.79 -21.43 -22.09 -22.13 -22.50
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Below are the top trends for Ceribell, Inc. (CBLL) based on the quarterly reports shown (Q1–Q4 2025, with context from 2024). The bullets are ordered to highlight positives first, then neutral data, then potential negatives.

  • Revenue growth: Ceribell's quarterly revenue rose across 2025, climbing from about $20.5 million in Q1 2025 to approximately $24.8 million in Q4 2025. This builds on a 2024 baseline where Q4 revenue was around $18.5 million, signaling improving top-line momentum.
  • Strong gross profit and stable margins: Gross profit in Q4 2025 was about $21.6 million on $24.8 million in revenue (roughly an 87% gross margin), up from Q4 2024 gross profit of about $16.2 million on $18.5 million in revenue, suggesting improved profitability on the product/service level.
  • Liquidity boost from investing activities: Net cash from continuing investing activities turned positive in Q4 2025 (roughly +$26 million), driven by sale/maturity of investments, which improves near-term liquidity.
  • Financing activity supports liquidity: Q4 2025 showed a positive net cash from financing activities, indicating continued access to external funding sources to support operations.
  • Solid balance-sheet liquidity window: Across 2025, the company carried sizeable liquid assets (cash and short-term investments) and a total asset base around the $190–$210 million range, providing a liquidity runway for execution of strategy.
  • Equity base remains relatively strong: Total equity in 2025 sits in the mid-to-high $160–$180 million range, with substantial common equity, which can cushion losses in the near term despite ongoing negative retained earnings.
  • Ongoing equity/financing activity: Ceribell engaged in common-equity financing activity in multiple 2025 quarters, reflecting reliance on external financing to support operations and growth initiatives.
  • Persistent net losses: Every 2025 quarter shows net income negative, with net losses in the range of roughly -$12.8M to -$13.5M and earnings per share around -$0.36 to -$0.37, indicating continued profitability challenges.
  • Operating cash flow burn continues: Net cash from operating activities remained negative in 2025 (e.g., Q4 -$10.8M, Q3 -$11.0M, Q2 -$7.5M, Q1 -$11.4M), highlighting ongoing cash burn from core operations.
  • Large cumulative deficits: Retained earnings are deeply negative (for example around -$180M+ by early 2025), reflecting a long history of losses despite revenue growth and an equity base, which poses ongoing longer-term risk to shareholders.
05/11/26 10:28 PM ETAI Generated. May Contain Errors.

CeriBell Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CeriBell's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CeriBell's net income appears to be on an upward trend, with a most recent value of -$53.41 million in 2025, rising from -$29.46 million in 2023. The previous period was -$40.46 million in 2024. See CeriBell's forecast for analyst expectations on what's next for the company.

CeriBell's total operating income in 2025 was -$58.40 million, based on the following breakdown:
  • Total Gross Profit: $78.27 million
  • Total Operating Expenses: $136.68 million

Over the last 2 years, CeriBell's total revenue changed from $45.23 million in 2023 to $89.06 million in 2025, a change of 96.9%.

CeriBell's total liabilities were at $40.47 million at the end of 2025, a 18.2% increase from 2024, and a 70.3% increase since 2023.

In the past 2 years, CeriBell's cash and equivalents has ranged from $34.50 million in 2023 to $194.37 million in 2024, and is currently $40.48 million as of their latest financial filing in 2025.

Over the last 2 years, CeriBell's book value per share changed from -21.16 in 2023 to 4.19 in 2025, a change of -119.8%.


Related Companies

Financial statements for NASDAQ:CBLL last updated on 4/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel